{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:30:08Z","timestamp":1774038608523,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.cyto.2018.11.019","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T17:58:44Z","timestamp":1542909524000},"page":"104-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Increased circulating granzyme B in type 2 diabetes patients with low-grade systemic inflammation"],"prefix":"10.1016","volume":"115","author":[{"given":"Flavia Agata","family":"Cimini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella","family":"D'Eliseo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0530-8568","authenticated-orcid":false,"given":"Ilaria","family":"Barchetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bertoccini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Velotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Gisella","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2018.11.019_b0005","series-title":"Global Report on Diabetes","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.cyto.2018.11.019_b0010","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2337\/diabetes.52.7.1799","article-title":"Atherosclerosis risk in communities study. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study","volume":"52","author":"Duncan","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.cyto.2018.11.019_b0015","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1471-0528.2006.01004.x","article-title":"Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue","volume":"113","author":"Cancello","year":"2006","journal-title":"B.J.O.G."},{"key":"10.1016\/j.cyto.2018.11.019_b0020","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nm.1964","article-title":"CD8 + effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity","volume":"15","author":"Nishimura","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2018.11.019_b0025","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ni.3120","article-title":"NK cells link obesity-induced adipose stress to inflammation and insulin resistance","volume":"16","author":"Wensveen","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2018.11.019_b0030","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.2337\/db07-0767","article-title":"Adipocyte death, adipose tissue remodeling, and obesity complications","volume":"56","author":"Strissel","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.cyto.2018.11.019_b0035","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1172\/JCI45887","article-title":"Adipose tissue remodeling and obesity","volume":"121","author":"Sun","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2018.11.019_b0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.cyto.2018.11.019_b0045","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00592-017-1039-1","article-title":"Circulating IL-8 levels are increased in patients with type 2 diabetes and associated with worse inflammatory and cardiometabolic profile","volume":"54","author":"Cimini","year":"2017","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.cyto.2018.11.019_b0050","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1210\/js.2017-00108","article-title":"WISP1 is a marker of systemic and adipose tissue inflammation in dysmetabolic subjects with or without type 2 diabetes","volume":"1","author":"Barchetta","year":"2017","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.cyto.2018.11.019_b0055","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.biochi.2012.06.030","article-title":"Adiponectin: anti-inflammatory and cardioprotective effects","volume":"94","author":"Villarreal-Molina","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.cyto.2018.11.019_b0060","doi-asserted-by":"crossref","first-page":"53e71","DOI":"10.1111\/j.1600-065X.1988.tb00749.x","article-title":"Granzymes a family of serine proteases released from granules of cytolytic T lymphocytes upon T cell receptor stimulation","volume":"103","author":"Jenne","year":"1988","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2018.11.019_b0065","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/eji.1830220426","article-title":"Differential expression of granzyme A and granzyme B proteases and their secretion by fresh rat natural killer (NK) and lymphokine-activated killer cells with NK phenotype (LAK-NK)","volume":"22","author":"Velotti","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2018.11.019_b0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.imlet.2007.05.004","article-title":"Macrophages express granzyme B in the lesion areas of atherosclerosis and rheumatoid arthritis","volume":"111","author":"Kim","year":"2007","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cyto.2018.11.019_b0075","doi-asserted-by":"crossref","first-page":"23549","DOI":"10.1074\/jbc.M412001200","article-title":"Extracellular matrix remodeling by human granzyme B via cleavage of vitronectin, fibronectin, and laminin","volume":"280","author":"Buzza","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2018.11.019_b0080","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/labinvest.2009.91","article-title":"Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma","volume":"89","author":"Boivin","year":"2009","journal-title":"Lab. Invest."},{"key":"10.1016\/j.cyto.2018.11.019_b0085","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/ijc.25135","article-title":"Granzyme B is expressed in urothelial carcinoma and promotes cancer cell invasion","volume":"127","author":"D'Eliseo","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cyto.2018.11.019_b0090","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.immuni.2014.11.012","article-title":"Granzyme B promotes cytotoxic lymphocyte transmigration via basement membrane remodeling","volume":"41","author":"Prakash","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2018.11.019_b0095","doi-asserted-by":"crossref","first-page":"732e741","DOI":"10.1016\/j.molmed.2012.09.009","article-title":"Granzyme B in injury, inflammation and repair","volume":"18","author":"Hiebert","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.cyto.2018.11.019_b0100","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nri3839","article-title":"Perforin and granzymes: function, dysfunction and human pathology","volume":"15","author":"Voskoboinik","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2018.11.019_b0105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.trecan.2017.04.001","article-title":"The untold story of granzymes in oncology: novel opportunities with old acquaintances","volume":"3","author":"Arias","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.cyto.2018.11.019_b0110","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.MP.0000067424.12280.BC","article-title":"Granzyme B in atherosclerosis and transplant vascular disease: association with cell death and atherosclerotic disease severity","volume":"16","author":"Choy","year":"2003","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.cyto.2018.11.019_b0115","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1016\/j.atherosclerosis.2007.05.001","article-title":"Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity","volume":"195","author":"Skjelland","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cyto.2018.11.019_b0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1139\/y06-090","article-title":"The role of Granzyme B in atheromatous diseases","volume":"85","author":"Chamberlain","year":"2007","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.cyto.2018.11.019_b0125","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jjcc.2009.06.009","article-title":"Plasma granzyme B as a predicting factor of coronary artery disease \u2013 clinical significance in patients with chronic renal failure","volume":"54","author":"Ikemoto","year":"2009","journal-title":"J. Cardiol."},{"key":"10.1016\/j.cyto.2018.11.019_b0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jjcc.2010.10.001","article-title":"Granzyme B as a novel factor involved in cardiovascular diseases","volume":"57","author":"Saito","year":"2011","journal-title":"J. Cardiol."},{"key":"10.1016\/j.cyto.2018.11.019_b0135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ajpath.2015.09.010","article-title":"Granzyme B deficiency protects against angiotensin ii-induced cardiac fibrosis","volume":"186","author":"Shen","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2018.11.019_b0140","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.4049\/jimmunol.1000021","article-title":"Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance","volume":"185","author":"Yang","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2018.11.019_b0145","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/jir.2013.0059","article-title":"The serine protease granzyme B as an inflammatory marker, in relation to the insulin receptor cleavage in human obesity and type 2 diabetes mellitus","volume":"34","author":"El Mesallamy","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.cyto.2018.11.019_b0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejogrb.2016.01.009","article-title":"Increased levels of serum granzyme-B is associated with insulin resistance and increased cardiovascular risk in adolescent polycystic ovary syndrome patients","volume":"198","author":"Oztas","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"Suppl 1","key":"10.1016\/j.cyto.2018.11.019_b0155","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc09-S013","article-title":"Standards of medical care in diabetes \u2013 2009","volume":"32","author":"American Diabetes Association","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cyto.2018.11.019_b0160","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(97)03062-6","article-title":"UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group","volume":"350","author":"Turner","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2018.11.019_b0165","doi-asserted-by":"crossref","first-page":"e0131837","DOI":"10.1371\/journal.pone.0131837","article-title":"Latent autoimmune diabetes in adults in the United Arab Emirates: clinical features and factors related to insulin-requirement","volume":"10","author":"Maddaloni","year":"2015","journal-title":"Plos One"},{"key":"10.1016\/j.cyto.2018.11.019_b0170","doi-asserted-by":"crossref","first-page":"3860674","DOI":"10.1155\/2017\/3860674","article-title":"High prevalence of autoimmune diabetes and poor glycaemic control among adults in Madagascar: a berief report from a humanitarian health campaign in Ambanja","volume":"2017","author":"Maddaloni","year":"2017","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.cyto.2018.11.019_b0175","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrendo.2017.99","article-title":"Adult-onset autoimmune diabetes: current knowledge and implications for management","volume":"13","author":"Buzzetti","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.cyto.2018.11.019_b0180","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cyto.2018.11.019_b0185","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cyto.2016.06.028","article-title":"Adiponectin, TNF-\u03b1 and inflammatory cytokines and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"86","author":"Liu","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2018.11.019_b0190","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2018.11.019_b0195","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2337\/db14-0444","article-title":"WISP1 is a novel adipokine linked to inflammation in obesity","volume":"64","author":"Murahovschi","year":"2015","journal-title":"Diabetes"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618304319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618304319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T18:56:47Z","timestamp":1550861807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466618304319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":39,"alternative-id":["S1043466618304319"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2018.11.019","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased circulating granzyme B in type 2 diabetes patients with low-grade systemic inflammation","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2018.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}